ESR1 and breast carcinoma: In the probe 222908_at, a positive correlation of PIEZO2 expression and survival in PR-positive and lymph node-positive breast cancer patients but a negative association between PIEZO2 expression and survival in ER-negative, HER2-positive and pathological grade 3 breast cancer patients were observed.